Back

Cardiovascular risk according to add-on therapy in patients with type 2 diabetes

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Diabetes, adiposity and metabolic syndrome Epidemiology ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr David Thein Aagaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

8 More presentations in this session

Presentation thumbnail
Doctor M. Husain (Toronto, CA)
Abstract Slides
Presentation thumbnail
Doctor T. Unoki (Kumamoto, JP)
Abstract
Presentation thumbnail
Professor B. Yan (Hong Kong, CN)
Abstract Slides
Presentation thumbnail
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Ms S. Michurina (Pavlovo, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Diabetes, adiposity and metabolic syndrome

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Session
Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
27 August 2023
thumbnail
Congress Presentation
Glucose lowering drugs or strategies, major adverse cardiovascular events and heart failure outcomes, and association with weight loss - meta-analysis of large cardiovascular outcome trials
2 September 2019
thumbnail
Congress Presentation
Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes
28 August 2020
thumbnail
Congress Presentation
Real world risk of major outcomes for type 2 diabetes with stable coronary artery disease without prior MI or stroke and THEMIS-like patients using the SNDS French nationwide claims database
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources